High-throughput methods leveraging robotics and computer vision for the development of therapeutic phage cocktails
Taylor J. R. Penke(Profectus Biosciences (United States)), Paul M. Garofolo(Profectus Biosciences (United States)), Ethan Baker(Profectus Biosciences (United States)), Nick Healy(University of Nevada, Reno), David G. Ousterout(Profectus Biosciences (United States)), Nicholas R. Conley(Profectus Biosciences (United States)), A. T. Hammack(Lawrence Berkeley National Laboratory), Cameron J. Prybol(Profectus Biosciences (United States)), Ava Ghobadian(Profectus Biosciences (United States)), Sara Woessner(Profectus Biosciences (United States)), Ashley Trama(Profectus Biosciences (United States)), Pearl Wilcock(Profectus Biosciences (United States)), Naomi Chavez(Profectus Biosciences (United States)), Eyra Dordi(Profectus Biosciences (United States)), Morgan K. Y. Wall(Lawrence Berkeley National Laboratory), Lana J. McMillan(Profectus Biosciences (United States)), Iain Wright(Profectus Biosciences (United States)), Hannah H. Tuson(Profectus Biosciences (United States))
Cited by 1
Related Papers
RNA-guided gene activation by CRISPR-Cas9–based transcription factors
|Nature Methods|2013|1.3k
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
|Science|2015|1.1k
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
|Nature Communications|2015|456
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
|Nucleic Acids Research|2014|388
Synergistic and tunable human gene activation by combinations of synthetic transcription factors
|Nature Methods|2013|241